The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling
Open accessAbstract
Repeated injections of adult mice with recombinant murine TNF prolong the survival of NZB/W F1 mice, and suppress type I insulin-dependent diabetes mellitus (IDDM) in nonobese diabetic (NOD) mice. To determine whether repeated TNF injections suppress T cell function in adult mice, we studied the responses of influenza hemagglutinin-specific T cells derived from T cell receptor (HNT-TCR) transgenic mice. Treatment of adult mice with murine TNF for 3 wk suppressed a broad range of T cell responses, including proliferation and cytokine production. Furthermore, T cell responses of HNT-TCR transgenic mice also expressing the human TNF-globin transgene were markedly reduced compared to HNT-TCR single transgenic littermates, indicating that sustained p55 TNF-R signaling is sufficient to suppress T cell function in vivo. Using a model of chronic TNF exposure in vitro, we demonstrate that (a) chronic TNF effects are dose and time dependent, (b) TNF suppresses the responses of both Th1 and Th2 T helper subsets, (c) the suppressive effects of endogenous TNF produced in T cell cultures could be reversed with neutralizing monoclonal antibodies to TNF, and (d) prolonged TNF exposure attenuates T cell receptor signaling. The finding that anti-TNF treatment in vivo enhances T cell proliferative responses and cytokine production provides evidence for a novel regulatory effect of TNF on T cells in healthy laboratory mice. These effects are more pronounced in chronic inflammatory disease. In addition, our data provide a mechanism through which prolonged TNF exposure suppresses disease in animal models of autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since inflammatory cytokines that direct T cell subtype production are altered in depressed patients (12–14)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,507
The Pathophysiology of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002211 · Cited by 1,874
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,675
Self-citationTumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,417
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. N. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,082
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 991
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 287
Czepielewski, R. S., Erlich, E. C., Onufer, E. J., Young, S., Saunders, B. T., Han, Y.-H., Wohltmann, M., Wang, P. L., Kim, K.-W., Kumar, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.003 · Cited by 77
Calcineurin and vacuolar-type H + -ATPase modulate macrophage effector functions
Conboy, I. M., Manoli, D. S., Mhaiskar, V., & Jones, P. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6324 · Cited by 76
Cope, A. P., Ettinger, R., & McDevitt, H. O. (1997) · Research in Immunology · doi:10.1016/s0923-2494(97)87239-2 · Cited by 74
Self-citationMueller, C., Corazza, N., Trachsel-Løseth, S., Eugster, H., Bühler-Jungo, M., Brunner, T., & Imboden, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38112 · Cited by 73
ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITIS
Kavanaugh, A. F. (1998) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70028-4 · Cited by 73
Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate
Jung, S., Siglienti, I., Grauer, O. M., Magnus, T., Scarlato, G., & Toyka, K. V. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.014 · Cited by 70
Green, E. A., Wong, F. S., Eshima, K., Mora, C., & Flavell, R. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.225 · Cited by 71
Tumor necrosis factor‐a and the progression of diabetes in non‐obese diabetic mice
Green, E. A., & Flavell, R. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01302.x · Cited by 68
Immune‐mediated regulation of chronic intestinal nematode infection
Hayes, K. S., Bancroft, A. J., & Grencis, R. K. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00193.x · Cited by 69
Moran, G. W., Lim, A., Bailey, J. L., Dubeau, M.-F., Leung, Y., Devlin, S. M., Novak, K. L., Kaplan, G. G., Iacucci, M., Seow, C. H., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12491 · Cited by 69
Raison, C. L., & Miller, A. H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.194 · Cited by 71
Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins
Khera, T. K., Dick, A. D., & Nicholson, L. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.003 · Cited by 67
Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation
Rouhani, F. N., Meitin, C. A., Kaler, M. M., Hilligoss, D. M., Stylianou, M. P., & Levine, S. J. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.02.031 · Cited by 67
Gordon, M. A., Oppenheim, E., Camp, N. J., di Giovine, F., Duff, G. W., & Gleeson, D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80220-7 · Cited by 79
Thompson, A., & Thomas, R. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01114.x · Cited by 64
Aravena, O., Pesce, B., Soto, L., Orrego, N., Sabugo, F., Wurmann, P., Molina, M. C., Jorge Alfaro, L., Cuchacovich, M., Aguillón, J. C., et al. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.006 · Cited by 66
Smeets, T. J. M., Dolhain, R. J. E. M., Miltenburg, A. M. M., de Kuiper, R., Breedveld, F. C., & Tak, P. P. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4525 · Cited by 61
Modulation of allergic inflammation in mice deficient in TNF receptors
Rudmann, D. G., Moore, M. W., Tepper, J. S., Aldrich, M. C., Pfeiffer, J. W., HogenEsch, H., & Tumas, D. B. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1047 · Cited by 61
Ji, Y. W., Byun, Y. J., Choi, W., Jeong, E., Kim, J. S., Noh, H., Kim, E. S., Song, Y. J., Park, S. K., & Lee, H. K. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11515 · Cited by 59
Neuroimmune mechanisms in K rabbe's disease
Potter, G. B., & Petryniak, M. A. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23804 · Cited by 58
TNF-α in Uveitis: From Bench to Clinic
Jiang, Q., Li, Z., Tao, T., Duan, R., Wang, X., & Su, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740057 · Cited by 59
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Mangat, P. K., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.001 · Cited by 58
Cytokines in the rheumatic diseases.
Arend, W., & Gabay, C. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00115-7 · Cited by 65
Taylor, K. R., Mills, R. E., Costanzo, A. E., & Jameson, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011422 · Cited by 59
Habil, N., Abate, W., Beal, J., & Foey, A. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0061 · Cited by 55
Church, L. D., Hessler, G., Goodall, J. E., Rider, D. A., Workman, C. J., Vignali, D. A. A., BACON, P. A., Gulbins, E., & Young, S. P. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003456 · Cited by 55
Immune Mechanisms of Uveitis: Insights Into Disease Pathogenesis and Treatment
Dick, A. D. (2000) · International Ophthalmology Clinics · doi:10.1097/00004397-200004000-00003 · Cited by 55
Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
Hazeldine, J., & Lord, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573662 · Cited by 55
T Cells as Sources and Targets of TNF: Implications for Immunity and Autoimmunity
Chatzidakis, I., & Mamalaki, C. (2010) · Current directions in autoimmunity · doi:10.1159/000289200 · Cited by 54
Glosli, H., Tronstad, K. J., Wergedal, H., Müller, F., Svardal, A. M., Aukrust, P., Berge, R. K., & Prydz, H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0948fje · Cited by 53
As we age: Does slippage of quality control in the immune system lead to collateral damage?
Müller, L., & Pawelec, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.005 · Cited by 52
Attenuated EAN in TNF-α Deficient Mice Is Associated with an Altered Balance of M1/M2 Macrophages
Zhang, H., Hassan, M. Y., Zheng, X., Azimullah, S., Quezada, H. C., Amir, N., Elwasila, M., Mix, E., Adem, A., & Zhu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038157 · Cited by 52
Bieber, J. D., & Kavanaugh, A. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.01.003 · Cited by 52
van der Sluijs, K. F., van Elden, L. J. R., Arens, R., Nijhuis, M., Schuurman, R., Florquin, S., Kwakkel, J., Akira, S., Jansen, H. M., Lutter, R., et al. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.02000.x · Cited by 52
Herrera, P. L., Harlan, D. M., & VASSALLI, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.279 · Cited by 52
Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis
Nagy, G., Clark, J. M., Buzás, E. I., Gorman, C., Pásztói, M., Koncz, Á., Falus, A., & Cope, A. P. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.02.009 · Cited by 51
Self-citationCopland, D. A., Liu, J., Schewitz-Bowers, L. P., Brinkmann, V., Anderson, K., Nicholson, L. B., & Dick, A. D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.008 · Cited by 50
Bosè, F., Raeli, L., Garutti, C., Frigerio, E., Cozzi, A., Crimi, M., Caprioli, F., Scavelli, R., Altomare, G. F., Geginat, J., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.01.015 · Cited by 50
Cytokine Gene Polymorphism in Sympathetic Ophthalmia
Atan, D., Turner, S. J., Kilmartin, D. J., Forrester, J. V., Bidwell, J. L., Dick, A. D., & Churchill, A. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0126 · Cited by 49
Role of TNF superfamily ligands in innate immunity
Vujanović, N. L. (2011) · Immunologic Research · doi:10.1007/s12026-011-8228-8 · Cited by 48
Lubahn, C. L., Lorton, D., Schaller, J. A., Sweeney, S. J., & Bellinger, D. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00346 · Cited by 48
Klareskog, L., & McDevitt, H. O. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00033-3 · Cited by 47
Self-citationImmunological Cytokine Correlates of Protective Immunity and Pathogenesis in Leprosy
Lima, M. C. B. S., Pereira, G. M. B., Rumjanek, F. D., Gomes, H. M., Düppre, N. C., Sampaio, E. P., Alvim, I. M. P., Nery, J. A. C., Sarno, E. N., & Pessolani, M. C. V. (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00703.x · Cited by 46
Ali, M., Ponchel, F., Wilson, K. E., Francis, M. J. D., Wu, X., Verhoef, A., Boylston, A. W., Veale, D. J., Emery, P., Markham, A. F., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8027 · Cited by 45
Immunopathology and the gene therapy of lupus
Mageed, R. A., & Prud’homme, G. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302016 · Cited by 44
Popescu, I., Snyder, M. E., Iasella, C. J., Hannan, S. J., Koshy, R., Burke, R., Das, A., Brown, M. J., Lyons, E. J., Lieber, S. C., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202111-2493oc · Cited by 46
Kollias, G. A., Kontoyiannis, D. L., Douni, E. K., & Kassiotis, G. (2001) · KARGER eBooks · doi:10.1159/000060546 · Cited by 42
Self-citationK-RAS GTPase- and B-RAF kinase–mediated T-cell tolerance defects in rheumatoid arthritis
Singh, K., Deshpande, P., Li, G., Yu, M., Pryshchep, S., Cavanagh, M., Weyand, C. M., & Goronzy, J. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117640109 · Cited by 41
Hayer, S., Tohidast-Akrad, M., Haralambous, S., Jahn‐Schmid, B., Skriner, K., Trembleau, S., Dumortier, H., Piñol-Roma, S., Redlich, K., Schett, G. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8327 · Cited by 41
Self-citationTumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production
Mageed, R. A., & Isenberg, D. A. (2002) · Lupus · doi:10.1191/0961203302lu306rr · Cited by 41
Can we vaccinate against depression?
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.018 · Cited by 39
Gonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 42
Tada, Y., Ho, A., Koarada, S., Morito, F., Ushiyama, O., Suzuki, N., Kikuchi, Y., Ohta, A., Mak, T. W., & Nagasawa, K. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5027 · Cited by 39
Immunomodulation at epithelial sites by obesity and metabolic disease
Cheung, K. P., Taylor, K. R., & Jameson, J. (2011) · Immunologic Research · doi:10.1007/s12026-011-8261-7 · Cited by 40
Fonollosa, A., Artaraz, J., Les, Í., Martínez-Berriotxoa, A., Pérez‐Izquierdo, J., López, Á. V., Gardeazaba, J., Berasategui, B., & Martínez-Alday, N. (2011) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.623212 · Cited by 39
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Al-Bogami, M. M., Muhammad, H. A., Alzabin, S., Mangat, P., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8610-y · Cited by 38
Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice
Yang, Y., & Santamaría, P. (2003) · Diabetologia · doi:10.1007/s00125-003-1218-1 · Cited by 37
Manipulating the Type 1 vs Type 2 Balance in Type 1 Diabetes
Christen, U., & von Herrath, M. G. (2004) · Immunologic Research · doi:10.1385/ir:30:3:309 · Cited by 37
Sjögren’s syndrome: current therapies remain inadequate for a common disease
Fox, R. I. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.9.2007 · Cited by 37
Hamilton, J. A. G., Lee, M., Hunter, R., Ank, R. S., Story, J. Y., Talekar, G. R., Sisroe, T., Ballak, D. B., Fedanov, A., Porter, C. C., et al. (2021) · Aging Cell · doi:10.1111/acel.13309 · Cited by 37
Westman, M., Saha, S., Morshed, M. M., & Lampa, J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04204.x · Cited by 37
Wagner, U. G., Pierer, M., Wahle, M., Moritz, F., Kaltenhäuser, S., & Häntzschel, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2825 · Cited by 35
Cope, A. P. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg262 · Cited by 34
Self-citationImmunotherapy of multiple sclerosis: the end of the beginning
Steinman, L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00266-1 · Cited by 34
Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
Dick, A. D., Siepmann, K., Dees, C., Duncan, L., Broderick, C. A., Liversidge, J., & Forrester, J. V. (1999) · PubMed · Cited by 33
Zhao, Y., Lajoie, G., Zhang, H., Chiu, B., Payne, U., & Inman, R. D. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1243-1251.2000 · Cited by 31
Wang, H., Li, H., Shi, F., Chambers, B. J., Link, H., & Ljunggren, H. (2000) · International Immunology · doi:10.1093/intimm/12.10.1381 · Cited by 31
Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies
Yung, R. L., Kaplan, M. M., Ray, D. W., Schneider, K. A., Mo, R.-R., Johnson, K. J., & Richardson, B. (2001) · Lupus · doi:10.1191/096120301701549660 · Cited by 31
TNFα Increases RANKL Expression via PGE2-Induced Activation of NFATc1
Park, H.-J., Baek, K., Baek, J., & Kim, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030495 · Cited by 32
Camelo, S. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00427-6 · Cited by 28
Müller, S., Rihs, S., Schneider, J., Paredes, B. E., Seibold, I., Brunner, T., & Mueller, C. (2009) · European Journal of Immunology · doi:10.1002/eji.200939554 · Cited by 28
Weishaupt, A., Gold, R., Härtung, T., Gaupp, S., Wendel, A., Brück, W., & Toyka, K. V. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.5.368 · Cited by 28
Tumor Necrosis Factor (TNF)–α and TNF Receptors in Viral Pathogenesis
Herbein, G., & O’Brien, W. A. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.2000.22335.x · Cited by 26
Evaluating candidate autoantigens in rheumatoid arthritis
Cope, A. P., & Sønderstrup, G. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00831997 · Cited by 26
Self-citationNeurologic Toxicities Associated with Tumor Necrosis Factor Inhibitors and Calcineurin Inhibitors
Coe, C. L., Horst, S., & Izzy, M. J. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.07.009 · Cited by 25
Genomic expression profiling of TNF-α-treated BDC2.5 diabetogenic CD4 + T cells
Lee, L.-F., Lih, C.-J., Huang, C.-J., Cao, T., Cohen, S. N., & McDevitt, H. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803336105 · Cited by 25
Self-citationImmunoregulation by Cytokines in Autoimmune Diabetes
Rabinovitch, A. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0171-8_10 · Cited by 25
Hooper, L. C., Chin, M. S., Detrick, B., & Hooks, J. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.018 · Cited by 24
Chatzidakis, I., Fousteri, G., Tsoukatou, D., Kollias, G. A., & Mamalaki, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6735 · Cited by 24
Self-citationFeedback Regulation of Murine Autoimmunity via Dominant Anti-Inflammatory Effects of Interferon γ
Minguela, A., Pastor, S., Mi, W., Richardson, J. A., & Ward, E. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.134 · Cited by 24
Kempsell, K. E., Cox, C. J., McColm, A. A., Bagshaw, J. A., Reece, R., Veale, D. J., Emery, P., Isaacs, J. D., Gaston, H., & Crowe, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1821-1831.2001 · Cited by 24
Clark, J. M., Annenkov, A. E., Panesar, M., Isomäki, P., Chernajovsky, Y., & Cope, A. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308231100 · Cited by 24
Self-citationAblamunits, V. G., Bisikirska, B. C., & Herold, K. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.000 · Cited by 23
Cesarini, M., Angelucci, E., Foglietta, T., & Vernia, P. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.06.010 · Cited by 23
Foxwell, B. M. J., Bondeson, J., Brennan, F., & Feldmann, M. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i54 · Cited by 23
Fang, C., Wang, L., Qiao, J., Chang, L., He, Q., Zhang, X., & Liu, M. R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108456 · Cited by 25
Aspalter, R. M., Eibl, M. M., & Wolf, H. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.004 · Cited by 22
MacArthur, G. J., Wilson, A. D., Birchall, M., & Morgan, A. J. (2007) · Journal of Virology · doi:10.1128/jvi.02608-06 · Cited by 22
van Lierop, M. J. C., den Hoed, L., Houbiers, J. G. A., Vencovský, J., Rùzicková, Š., Kryštůfková, O., van Schaardenburg, M., van den Hoogen, F. H. J., Vandooren, B., Baeten, D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22651 · Cited by 22
Cytokines and Chemokines in the Pathogenesis of Murine Type 1 Diabetes
Meagher, C. T., Sharif, S., Hussain, S., Cameron, M. J., Arreaza, G., & Delovitch, T. L. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0171-8_9 · Cited by 22
Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation
Schmid, T., Falter, L., Weber, S., Müller, N. C., Molitor, K., Zeller, D., Weber‐Steffens, D., Hehlgans, T., Wajant, H., Mostböck, S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01471 · Cited by 21
Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-?? Therapy in Ankylosing Spondylitis
Keyser, F. D., Baeten, D., den Bosch, F. E. V., Kruithof, E., Verbruggen, G., Mielants, H., & VEYS, E. M. (2004) · Drugs · doi:10.2165/00003495-200464240-00005 · Cited by 21
Lymphoid Microstructures in Rheumatoid Synovitis
Weyand, C. M., Braun, A. B., Takemura, S., & Goronzy, J. J. (2000) · KARGER eBooks · doi:10.1159/000060521 · Cited by 21
Tuberculosis and opportunistic infections: relevance to biologic agents.
Bieber, J. D., & Kavanaugh, A. (2004) · PubMed · Cited by 20
Left-Sided Cardiac Valvulitis in Tristetraprolin-Deficient Mice
Ghosh, S. T., Hoenerhoff, M. J., Clayton, N. P., Myers, P., Stumpo, D. J., Maronpot, R. R., & Blackshear, P. J. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090498 · Cited by 20
Fatal Varicella-Zoster Virus Vasculopathy Associated With Adalimumab Therapy
Baek, W., Lee, S.-G., Kim, Y. S., Kim, J., Jun, J., & Kim, H. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3741 · Cited by 19
Drug-Induced Demyelinating Neuropathies
Niimi, N., Takaku, S., Yako, H., & Sango, K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9636-7_23 · Cited by 19
Ge, L., Baskić, D., Basse, P. H., Vujanovic, L. N., Unlu, S., Yoneyama, T., Vujanovic, A., Han, J., Banković, D., Szczepański, M. J., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0898 · Cited by 19
Peluso, R., Cafaro, G., Minno, A. D., Iervolino, S., Ambrosino, P., Lupoli, G., & Minno, M. N. D. D. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2252-0 · Cited by 18
Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc
Richter, F., Seifert, O., Herrmann, A., Pfizenmaier, K., & Kontermann, R. E. (2019) · mAbs · doi:10.1080/19420862.2019.1596512 · Cited by 18
Metadata
- Authors
- Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O.
- Affiliations
- Washington University in St. Louis (US)
- From the *Department of Microbiology and Immunology, ‡Department of Pathology, and §Department of Medicine, Stanford University School of Medicine, Stanford, California 94305; ‖Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110; and ¶Department of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-05-05
- Volume
- 185
- Issue
- 9
- Pages
- 1573-1584
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2196294
- OpenAlex
- W2153191296
- Cited by
- 287
- References
- 38
- Citations by year
- 2026: 3 · 2025: 4 · 2023: 4 · 2022: 1 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 11 · 2015: 6 · 2014: 11 · 2013: 8 · 2012: 13
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
- School of Medicine, Stanford University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- TNF-α, T cell receptor signaling, T cell suppression, TNF receptor p55, T cell proliferation, cytokine production, anti-TNF therapy, autoimmunity, type 1 diabetes, chronic inflammation
- MeSH terms
- Animals, Calcium, Immunosuppressive Agents, Interferon-gamma, Interleukin-2, Lymph Nodes, Lymphocyte Activation, Male, Mice, Inbred BALB C, Mice, Transgenic, Receptors, Antigen, T-Cell, Recombinant Proteins, T-Lymphocytes, Tumor Necrosis Factor-alpha, Signal Transduction, CD4-Positive T-Lymphocytes, Interleukin-4, Interleukin-10, Receptors, Tumor Necrosis Factor, Th1 Cells, Th2 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review